The director of the Blood and Bone Marrow Transplantation program

Biography – Prof. Nadir Arber, MD, MSc, MHA
Prof. Nadir Arber serves as the Director of the Integrated Cancer Prevention
Center (ICPC) at Tel Aviv Sourasky Medical Center in Tel Aviv.
Nadir Arber (MD, MSc, MHA) is a full Professor of Medicine and
Gastroenterology, and is a holder of the Yechiel and Helen Lieber chair for
Cancer Research at Tel Aviv Souraski Medical Center and Tel Aviv
University, Sackler School of Medicine.
Dr Arber is currently heading the
grants committee of the Sackler School of Medicine at Tel Aviv University.
Dr. Arber, a noted expert in the field of early detection and prevention, has
been serving as the principal investigator (PI) of the ICPC research laboratory
and in several international, multicenter clinical trials in the field of early
detection, prevention and therapy of gastrointestinal (GI) malignancies using
NSAIDs and in particular, colorectal cancer (CRC).
Dr. Arber graduated at the Medical School in Hadassah, Jerusalem, in 1987
(Magna Cum Laude). Residency in internal medicine was performed at the
Rabin Medical Center (1987-1991), and fellowship in Gastroenterology at Tel
Aviv Souraski Medical Center (1991-1993). Three years of research
fellowship were performed in Columbia University, NY, at the laboratory of Dr.
Bernard Weinstein. Since 1999, Dr. Arber has been the Head of the GI
Oncology Unit at the Department of Gastroenterology, Tel Aviv Souraski
Medical Center. In 2002, he became the Head of the ICPC. His department
has a significant and diverse experience in translational research focused on
early detection, prevention and therapy of cancer, in particular tumors of the
GI tract.
Dr. Arber has extensive experience in clinical studies, molecular epidemiology
as well as in molecular and cell biology studies of cancer. He had published
more than 302 articles in per-reviewed journals, reviews and chapters in
books, and received more than 90 research grants and awards. Currently, his
on-going researches focus on translational research, bridging between basic
researches in the lab and clinicians and patients in the clinical center. He
established, with Bernard Levin and other colleagues, an International
Consortium of leading clinicians, from 110 hospitals spanning 32 countries. In
house, this collaboration is mainly conducted with the departments of
Gastroenterology and Oncology.